QI
SYNH

Quotient Investors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Quotient Investors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.36M Buy
+26,000
New +$1.45M 0.93% 37
2016
Q3 		– Sell
-15,046
Closed -$574K – 221
2016
Q2 		$574K Buy
+15,046
New +$661K 0.27% 111

Other funds holding SYNH

THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Quotient Investors's SYNH Position: Q3 2017 in Review

Quotient Investors opened a new position in Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2017: 26,000 shares worth $1.36M. The stake represents 0.93% of the portfolio and ranks #37 among its holdings. This is a return to the name: Quotient Investors previously reported a position in SYNH as recently as Q2 2016.

Quotient Investors first reported a position in SYNH in Q2 2016 and has held it in 2 quarters since. 238 funds tracked by Wall St. Rank hold SYNH as of Q3 2017.

  • Quotient Investors held 26,000 shares of Syneos Health, Inc. Class A Common Stock worth $1.36M as of Q3 2017.
  • Syneos Health, Inc. Class A Common Stock was a new Quotient Investors position in Q3 2017.
  • Syneos Health, Inc. Class A Common Stock made up 0.93% of Quotient Investors's portfolio in Q3 2017, its #37 holding.
  • Quotient Investors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and has held it in 2 quarters since.
  • 238 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.